Specifically, a study revealed that AIM2 expression was predominantly low (negative and weak) in approximately two-thirds of the 298 RCC biopsy specimens, while high (moderate and strong) expression was observed in the remaining one-third of biopsy samples47. Here, AIM2 is linked to renal cell carcinoma.